United Therapeutics
UTHR
$226.03
Share price
-2.77%
Change (1 day)
-1.09%
Change (1 year)
Categories
United Therapeutics (UTHR) - Cash on Hand
Cash on Hand as of June 2023 : $4.70 B
According to United Therapeutics's latest financial reports the company has $4.70 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
United Therapeutics - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $4.15 B | 16.04% |
| 2021-12-31 | $3.58 B | 19.97% |
| 2020-12-31 | $2.98 B | 32.45% |
| 2019-12-31 | $2.25 B | 21.25% |
| 2018-12-31 | $1.85 B | 29.96% |
| 2017-12-31 | $1.43 B | 36.1% |
| 2016-12-31 | $1.05 B | 10.17% |
| 2015-12-31 | $0.95 B | 37.13% |
| 2014-12-31 | $0.69 B | 1.02% |
| 2013-12-31 | $0.68 B | 43.68% |
| 2012-12-31 | $0.47 B | 18.77% |
| 2011-12-31 | $0.40 B | -35.66% |
| 2010-12-31 | $0.62 B | 173.25% |
| 2009-12-31 | $0.22 B | -2.78% |
| 2008-12-31 | $0.23 B | -18.62% |
| 2007-12-31 | $0.29 B | 27.36% |
| 2006-12-31 | $0.22 B | 81.5% |
| 2005-12-31 | $0.12 B | 51.58% |
| 2004-12-31 | $82.78 M | 20.75% |
| 2003-12-31 | $68.56 M | -44.1% |
| 2002-12-31 | $0.12 B | 118.83% |
| 2001-12-31 | $56.04 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $19.97 B | 324.70% | 🇺🇸 USA |
 Eli Lilly LLY | $2.82 B | -39.84% | 🇺🇸 USA |
 Baxter BAX | $1.72 B | -63.38% | 🇺🇸 USA |
 Gilead Sciences GILD | $8.00 B | 70.14% | 🇺🇸 USA |
 Cardinal Health CAH | $4.04 B | -14.03% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $8.20 B | 74.47% | 🇬🇧 UK |
 Cytokinetics
CYTK | $0.56 B | -87.97% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $2.66 B | -43.24% | 🇮🇱 Israel |